semaglutide prediabetes weight loss trial progression to diabetes SCALE (NEJM 2015) was the pivotal for liraglutide 3.0 mg — the first GLP-1 RA approved for chronic management. In 3,731 adults with obesity, it produced 8.0% mean weight In the REDEFINE 2 phase

Tirzepatide, found in both Mounjaro and Zepbound, operates by targeting two key receptors: GLP-1 Receptor Effects Activation of the GLP-1 receptor by Tirzepatide helps reduce appetite and prolongs feelings of fullness, also moderating blood sugar levels by stimulating insulin when needed

Liraglutide and tirzepatide work through similar appetite- and digestion-regulating pathways and share many of the same side effects, including nausea, vomiting, diarrhea, and constipation

If you are using CareCredit or Cherry for extended financing, align your repayment timeline with your expected treatment duration

Experiment and see what works for your body and schedule

Body weight reduction was similar across all the quartiles of SBP baseline value (tirzepatide 5 mg 6.8 kg to 7.3 kg